These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38238944)

  • 1. [Strategies for liver injury caused by hepatocellular carcinoma targeted therapy].
    Zhao SX; Liu SH; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1129-1132. PubMed ID: 38238944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma].
    Zhang DZ; Niu JQ
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):834-837. PubMed ID: 31941237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status and treatment strategies for liver injury before targeted immunotherapy for liver cancer].
    Jia JM; Ren JS; Zhang LY
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1133-1136. PubMed ID: 38238945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma.
    Liu Z; Lin Y; Zhang J; Zhang Y; Li Y; Liu Z; Li Q; Luo M; Liang R; Ye J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):447. PubMed ID: 31684985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The companion diagnostics of targeted therapy and immunotherapy for hepatocellular carcinoma].
    Huang XW; Liu SH; Zhao JM
    Zhonghua Gan Zang Bing Za Zhi; 2022 Sep; 30(9):912-917. PubMed ID: 36299182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
    Zhu J; Yin T; Xu Y; Lu XJ
    J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the comparison of postoperative liver injury caused by hepatic arterial perfusion chemotherapy combined with targeted immunotherapy with hepatic arterial chemoembolization combined with targeted immunotherapy for intermediate-and advanced-stage liver cancer].
    Li R; Li WL; Yuan GS; Pang HJ; Li Q; Hu XY; Guo YB; Chen JZ; Zang MY
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1163-1168. PubMed ID: 38238949
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion of primary liver cancer after targeted therapy for liver cancer combined with AFP-targeted CAR T-cell therapy: a case report.
    Wang Y; Zhao Y; Li M; Hou H; Jian Z; Li W; Li P; Ma F; Liu M; Liu H; Xue H
    Front Immunol; 2023; 14():1180001. PubMed ID: 37256142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Hepatocellular carcinoma: A life-threatening disease".
    Chacko S; Samanta S
    Biomed Pharmacother; 2016 Dec; 84():1679-1688. PubMed ID: 27823920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma.
    Wang T; Zhang Q; Wang N; Liu Z; Zhang B; Zhao Y
    Curr Med Chem; 2021; 28(16):3107-3146. PubMed ID: 33050856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Emphasis on targeted and immunotherapy for liver injury in hepatocellular carcinoma].
    Nan YM; Liu LD; Zhao SX
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1121-1124. PubMed ID: 38238942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Therapeutic Options for Advanced Hepatocellular Carcinoma.
    Ma YS; Liu JB; Wu TM; Fu D
    Cancer Control; 2020; 27(3):1073274820945975. PubMed ID: 32799550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights.
    Shokoohian B; Negahdari B; Aboulkheyr Es H; Abedi-Valugerdi M; Baghaei K; Agarwal T; Maiti TK; Hassan M; Najimi M; Vosough M
    J Cell Mol Med; 2021 Sep; 25(18):8602-8614. PubMed ID: 34423899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of the advanced HCC: A second revolution by using immunotherapy].
    Fartoux L; Rosmorduc O
    Biol Aujourdhui; 2018; 212(3-4):85-87. PubMed ID: 30973137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for hepatocellular carcinoma.
    Li S; Yang F; Ren X
    Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The advanced development of molecular targeted therapy for hepatocellular carcinoma.
    Yan T; Yu L; Zhang N; Peng C; Su G; Jing Y; Zhang L; Wu T; Cheng J; Guo Q; Shi X; Lu Y
    Cancer Biol Med; 2022 Jun; 19(6):802-17. PubMed ID: 35699406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Therapy for Hepatocellular Carcinoma: Advances and Hopes.
    Zhang CH; Li M; Lin YP; Gao Q
    Curr Gene Ther; 2020; 20(2):84-99. PubMed ID: 32600231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress of immunotherapy alone and in combination for liver cancer].
    Wu ZJL; Li K; Zhang K; Gong WD
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):471-474. PubMed ID: 32660173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and prognostic analysis of transarterial chemoembolization combined with targeted immunotherapy in the treatment of patients with hepatitis B virus-related intermediate-and advanced-stage hepatocellular carcinoma with secondary cholestasis].
    Wang NN; Shen JM; Li HL; Wang X; Yang GD; Pan XC; Li J
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1149-1155. PubMed ID: 38238947
    [No Abstract]   [Full Text] [Related]  

  • 20. Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma.
    Zhao M; Huang H; He F; Fu X
    Front Immunol; 2023; 14():1188277. PubMed ID: 37275909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.